Sublingual Immunotherapy Not Currently Recommended For Asthma Control – Medical Research News and Interviews on MedicalResearch.com (blog)

Sublingual Immunotherapy Not Currently Recommended For Asthma Control
Medical Research News and Interviews on MedicalResearch.com (blog)
Response: Asthma is a common, long-term, respiratory condition which affects over 300 million people worldwide. It is a burden not only for the individual with asthma but also for the health services that care for them and the wider economy, due to

View full post on asthma – Google News

New care model for M?ori children with asthma recommended – Medical Xpress – Medical Xpress

New care model for M?ori children with asthma recommended – Medical Xpress
Medical Xpress
A new University of Otago, Wellington, research report has found that the main barriers to optimal health literacy—and therefore optimal care for M?ori children with asthma—are structural and endemic to New Zealand's acute care model of health delivery.

View full post on asthma – Google News

Study shows cost-effective expert recommended asthma test underutilized by … – Medical Xpress

Study shows cost-effective expert recommended asthma test underutilized by
Medical Xpress
Researchers from the University of Texas Medical Branch at Galveston have found, for the first time, that spirometry was underutilized for asthma diagnosis and management in U.S. adults from 2001 to 2011, despite it's accuracy, cost effectiveness and

View full post on asthma – Google News

Single Combined Asthma Inhaler Better Than Recommended Treatment – Medical News Today


Telegraph.co.uk

Single Combined Asthma Inhaler Better Than Recommended Treatment
Medical News Today
Using two asthma medications combined in a single inhaler provides superior rescue and preventive treatment than guideline-based treatments among adults whose asthma symptoms are not well controlled, according to two large, randomized clinical trials
Combo Inhaler May Give Better Relief for Some With AsthmaU.S. News & World Report
Single inhaler asthma therapy betterWebMD.Boots.com
Dual-purpose asthma inhalers more effectiveTelegraph.co.uk
Exchange Morning Post (press release)
all 5 news articles »

View full post on asthma – Google News

Recommended: Shadid’s death highlights dangers of asthma – msnbc.com


Telegraph.co.uk

Recommended: Shadid's death highlights dangers of asthma
msnbc.com
16, 2012, apparently of an asthma attack, while on assignment for the New York Times in Syria, the paper said. He was 43. By Linda Carroll Journalist Anthony Shadid's sudden death has many wondering how an apparently healthy 43-year-old man could be
New York Times reporter Anthony Shadid dies in Syria after asthma attackTelegraph.co.uk
New York Times Correspondent Shadid Dies in SyriaABC News
The man who brought the Arab Spring homeIndian Express
Huffington Post (blog) –RollingStone.com (blog)
all 19 news articles »

View full post on asthma – Google News

Recommended: Q&A: Cats and cat allergies on a plane – msnbc.com


MarketWatch

Recommended: Q&A: Cats and cat allergies on a plane
msnbc.com
“If I have an allergy attack, it manifests as asthma that could not only cause a trip to the hospital, at best, but also typically means I will be recovering for days after receiving treatment,” wrote Ambler. He tries to call ahead to see if there
Atchoo! How to battle dust-mite allergiesMarketWatch

all 2 news articles »

View full post on asthma – Google News

PPIs Not Recommended for Routine Treatment of Adult Asthma – Medscape

PPIs Not Recommended for Routine Treatment of Adult Asthma
Medscape
April 11, 2011 — Proton pump inhibitor (PPI) therapy in adults with asthma shows a small, statistically, but not clinically, significant improvement in the morning peak expiratory flow (PEF) rate, according to the results of a meta-analysis reported
The Efficacy of Proton Pump Inhibitors for the Treatment of Asthma in Adults A Archives of Internal Medicine

all 2 news articles »

View full post on asthma – Google News

Asthma Worse In Children, Novartis’ Xolair Recommended – Medical News Today


LiveScience.com

Asthma Worse In Children, Novartis' Xolair Recommended
Medical News Today
A new study suggests that Novartis drug Xolair may aid in the treatment of asthma, the leading cause of chronic illness in children, especially for those living in highly polluted inner-city areas. Asthma affects as many as 10% to 12% of children in
Omalizumab 'cuts seasonal asthma attacks in youth'Sify
Omalizumab improves asthma control in inner-city childrenClinical Advisor
Drug may relieve kids' asthma in the fallmsnbc.com
MedPage Today –WebMD –U.S. News & World Report
all 50 news articles »

View full post on asthma – Google News